Skip to main content
. 2011 Sep 30;43(3):181–188. doi: 10.4143/crt.2011.43.3.181

Fig. 2.

Fig. 2

Kaplan-Meier analyses of overall survival in 194 patients with gastroenteropancreatic neuroendocrine tumors. (A) Cyclooxygenase-2: solid line, no overexpression; dotted line, overexpression. (B) Ki-67: solid line, G1; dotted line, G2 or G3. (C) Somatostatin receptor 2: solid line, positive; dotted line, negative.